Lithium-associated hypothyroidism and thyroid papillary carcinoma: a case report

South Med J. 2006 Mar;99(3):279-81. doi: 10.1097/01.smj.0000203332.70689.b6.

Abstract

Ionizing radiation, some hereditary factors, and chronic thyroid-stimulating hormone elevation increases the risk of differentiated thyroid carcinoma. Lithium salts are used in the treatment of affective (mood) disorders as well as a variety of other psychiatric conditions. There have been occasional reports of hematologic and solid neoplasms associated with lithium use. We report a patient who developed hypothyroidism and subsequently, thyroid papillary carcinoma while on lithium treatment for bipolar affective disorder.

Publication types

  • Case Reports

MeSH terms

  • Antidepressive Agents / adverse effects*
  • Antidepressive Agents / therapeutic use
  • Biopsy, Fine-Needle
  • Bipolar Disorder / drug therapy
  • Carcinoma, Papillary / chemically induced*
  • Carcinoma, Papillary / complications
  • Carcinoma, Papillary / pathology
  • Follow-Up Studies
  • Humans
  • Hypothyroidism / blood
  • Hypothyroidism / chemically induced*
  • Hypothyroidism / complications
  • Lithium Carbonate / adverse effects*
  • Lithium Carbonate / therapeutic use
  • Male
  • Middle Aged
  • Thyroid Neoplasms / chemically induced*
  • Thyroid Neoplasms / complications
  • Thyroid Neoplasms / pathology
  • Thyrotropin / blood

Substances

  • Antidepressive Agents
  • Lithium Carbonate
  • Thyrotropin